Structures by: Ferreira M. D.
Total: 22
N-phenylpyrazinecarboxamide
C11H9N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9716(3)Å b=7.5270(4)Å c=11.0318(6)Å
α=83.295(3)° β=85.377(4)° γ=69.009(3)°
N-(2-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=15.5361(9)Å b=7.0360(3)Å c=18.9863(9)Å
α=90.00° β=91.307(2)° γ=90.00°
N-(3-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.2736(4)Å b=10.8639(4)Å c=18.5040(5)Å
α=90.00° β=90.1970(19)° γ=90.00°
N-(2-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.6748(3)Å b=7.8967(3)Å c=9.8421(5)Å
α=96.682(2)° β=103.357(3)° γ=101.659(2)°
N-(4-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8885(6)Å b=7.5257(9)Å c=13.2762(16)Å
α=78.349(7)° β=86.460(8)° γ=70.146(8)°
N-(4-fluorophenyl)pyrazinecarboxamide, P2~1~/c polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=11.718(2)Å b=5.9726(10)Å c=13.474(2)Å
α=90.00° β=91.446(9)° γ=90.00°
N-(3-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.9121(3)Å b=10.9457(3)Å c=18.6827(4)Å
α=90.00° β=92.026(2)° γ=90.00°
N-(4-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8636(3)Å b=7.2433(5)Å c=13.1459(9)Å
α=100.854(3)° β=97.750(4)° γ=110.783(4)°
N-(4-fluorophenyl)pyrazinecarboxamide, Pc polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9666(3)Å b=24.2205(15)Å c=13.0262(7)Å
α=90.00° β=91.720(3)° γ=90.00°
N-(2-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.1667(4)Å b=20.7513(6)Å c=7.4516(3)Å
α=90.00° β=90.00° γ=90.00°
N-(3-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2,H2O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.9386(2)Å b=8.5820(3)Å c=19.0670(6)Å
α=90.00° β=99.394(2)° γ=90.00°
N-(2-nitrophenyl)pyrazinecarboxamide?
C11H8N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=3.6598(2)Å b=21.7123(17)Å c=13.1158(10)Å
α=90.00° β=91.281(5)° γ=90.00°
N-(2,6-dimethylphenyl)pyrazinecarboxamide
C13H13N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.3977(4)Å b=10.7671(5)Å c=15.2457(4)Å
α=90.00° β=101.665(3)° γ=90.00°
N-(2-chloro-4-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=18.733(4)Å b=3.8502(8)Å c=14.839(3)Å
α=90.00° β=99.472(3)° γ=90.00°
N-(4-chloro-2-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.8885(2)Å b=10.5369(5)Å c=14.6683(7)Å
α=90.00° β=99.008(3)° γ=90.00°
(3<i>S</i>,4a<i>S</i>,8a<i>S</i>)-2-[(2<i>R</i>,3<i>S</i>)-3-Benzamido-2-benzoyloxy-4-phenylbutyl]-<i>N</i>-<i>tert</i>-butyldecahydroisoquinoline-3-carboxamide
C38H47N3O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 913-917
a=11.4866(3)Å b=9.4448(2)Å c=16.8257(5)Å
α=90° β=109.227(3)° γ=90°
(3<i>S</i>,4a<i>S</i>,8a<i>S</i>)-2-[(2<i>R</i>,3<i>S</i>)-3-(2,5-Dichlorobenzamido)-2-(2,5-dichlorobenzoyloxy)-4-phenylbutyl]-<i>N</i>-<i>tert</i>-butyldecahydroisoquinoline-3-carboxamide
C38H43Cl4N3O4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 6 913-917
a=10.45390(10)Å b=15.19170(10)Å c=24.3677(2)Å
α=90° β=90° γ=90°
2,3-dichlorobenzaldehyde isonicotinoylhydrazone
C13H9Cl2N3O
Acta Crystallographica Section C (2005) 61, 10 o617-o620
a=7.7369(2)Å b=10.7764(4)Å c=14.9091(5)Å
α=90.00° β=90.2400(18)° γ=90.00°
2,4-difluorobenzaldehyde isonicotinoylhydrazone
C13H9F2N3O
Acta Crystallographica Section C (2005) 61, 10 o617-o620
a=6.8859(3)Å b=24.7258(12)Å c=7.2582(2)Å
α=90.00° β=107.953(2)° γ=90.00°
N-(4-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.0039(3)Å b=5.6916(2)Å c=13.3466(3)Å
α=90.00° β=101.6381(12)° γ=90.00°
N-(2,6-difluorophenyl)pyrazinecarboxamide
C11H7F2N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.8054(4)Å b=10.9355(5)Å c=19.4805(9)Å
α=90.00° β=103.474(2)° γ=90.00°
N-(2-methyl-5-nitrophenyl)pyrazinecarboxamide
C12H10N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.4767(5)Å b=14.5930(6)Å c=7.7136(3)Å
α=90.00° β=93.433(3)° γ=90.00°